4-aminobutyric acid

4-aminobutyric acid is a lipid of Fatty Acyls (FA) class. 4-aminobutyric acid is associated with abnormalities such as Epilepsy and Premenstrual syndrome. The involved functions are known as Binding (Molecular Function), neuron survival, Process, Uptake and physiological aspects. 4-aminobutyric acid often locates in Microglial, Neurofilament, Neuraxis, Brain region and Neurites. The associated genes with 4-aminobutyric acid are arginine methyl ester, SLC33A1 gene, NKS1 gene, P4HTM gene and ITSN2 gene. The related lipids are pregnenolone sulfate, pregnane-20-one, Pregnanes, Steroids and endogenous steroids.

Cross Reference

Introduction

To understand associated biological information of 4-aminobutyric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-aminobutyric acid?

4-aminobutyric acid is suspected in Premenstrual syndrome, Epilepsy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 4-aminobutyric acid

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Sarcoma, Experimental D012513 13 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Acidosis, Lactic D000140 8 associated lipids
Lung Neoplasms D008175 171 associated lipids
Hyperglycemia D006943 21 associated lipids
Wounds and Injuries D014947 20 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Ketosis D007662 13 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Coronary Disease D003327 70 associated lipids
Hepatic Encephalopathy D006501 9 associated lipids
Hypothyroidism D007037 32 associated lipids
Substance Withdrawal Syndrome D013375 9 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Pain, Postoperative D010149 13 associated lipids
Occupational Diseases D009784 42 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Brain Diseases D001927 27 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Genetic Diseases, Inborn D030342 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Hyperplasia D006965 34 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Fetal Diseases D005315 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Cerebral Hemorrhage D002543 13 associated lipids
Nervous System Diseases D009422 37 associated lipids
Hypoparathyroidism D007011 2 associated lipids
Ataxia D001259 20 associated lipids
Brain Edema D001929 20 associated lipids
Alcoholism D000437 27 associated lipids
Starvation D013217 47 associated lipids
Creutzfeldt-Jakob Syndrome D007562 7 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Hypocalcemia D006996 12 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hyperthyroidism D006980 12 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Movement Disorders D009069 3 associated lipids
Protein-Energy Malnutrition D011502 9 associated lipids
Cushing Syndrome D003480 5 associated lipids
Granuloma, Foreign-Body D015745 5 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Epilepsies, Partial D004828 3 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Hamartoma D006222 2 associated lipids
Muscular Diseases D009135 7 associated lipids
Hyperlipidemias D006949 73 associated lipids
Morphine Dependence D009021 9 associated lipids
Cough D003371 19 associated lipids
Herpes Simplex D006561 3 associated lipids
Catalepsy D002375 30 associated lipids
Death, Sudden D003645 12 associated lipids
Tachycardia D013610 7 associated lipids
Meningioma D008579 11 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Hypoxia, Brain D002534 5 associated lipids
Migraine Disorders D008881 11 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Adenoma D000236 40 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Reye Syndrome D012202 14 associated lipids
Per page 10 20 50 100 | Total 280

PubChem Associated disorders and diseases

What pathways are associated with 4-aminobutyric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-aminobutyric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-aminobutyric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-aminobutyric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-aminobutyric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-aminobutyric acid

Download all related citations
Per page 10 20 50 100 | Total 40318
Authors Title Published Journal PubMed Link
pmid:10103070
pmid:10102500
pmid:10101733
Huang RQ et al. The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors. 1999 Brain Res. Mol. Brain Res. pmid:10101245
pmid:10101240
Veggiotti P et al. Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study. 1999 Acta Neurol. Scand. pmid:10100956
Ruzhinskaia NN [Receptor responses to amino acids recorded from the surface of the olfactory bulb]. 1976 Fiziol Zh SSSR Im I M Sechenova pmid:1010066
Hammond JB and Ahmad F Hepatic encephalopathy and role of antibenzodiazepines. 1998 Am J Ther pmid:10099035
Ros-Moreno RM et al. Interaction of ivermectin with gamma-aminobutyric acid receptors in Trichinella spiralis muscle larvae. 1999 Parasitol. Res. pmid:10099015
Reynolds GP et al. Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation. 1999 J. Neurochem. pmid:10098889
Vadivelu N and Berger J Neuropathic pain after anti-HIV gene therapy successfully treated with gabapentin. 1999 J Pain Symptom Manage pmid:10098357
Leigh RJ and Ramat S Neuropharmacologic aspects of the ocular motor system and the treatment of abnormal eye movements. 1999 Curr. Opin. Neurol. pmid:10097880
Berkley KJ Sex differences in pain. 1997 Behav Brain Sci pmid:10097000
Pencheva N et al. Comparison of gamma-aminobutyric acid effects in different parts of the cat ileum. 1999 Eur. J. Pharmacol. pmid:10096769
Kurozumi Y et al. Experimental beta-alaninuria induced by (aminooxy)acetate. 1999 Acta Med. Okayama pmid:10096733
Gonçalves PP et al. Regulation of the gamma-aminobutyric acid transporter activity by protein phosphatases in synaptic plasma membranes. 1999 Neurosci. Res. pmid:10096470
Kitahara T et al. Molecular mechanisms of vestibular compensation in the central vestibular system--review. 1998 Acta Otolaryngol Suppl pmid:10095856
Feng L et al. Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. 1999 Brain Res. Mol. Brain Res. pmid:10095078
Hylland P and Nilsson GE Extracellular levels of amino acid neurotransmitters during anoxia and forced energy deficiency in crucian carp brain. 1999 Brain Res. pmid:10095011
Yoon YH et al. High vulnerability of GABA-immunoreactive neurons to kainate in rat retinal cultures: correlation with the kainate-stimulated cobalt uptake. 1999 Brain Res. pmid:10095009
Stringer JL and Lorenzo N The reduction in paired-pulse inhibition in the rat hippocampus by gabapentin is independent of GABA(B) receptor receptor activation. 1999 Epilepsy Res. pmid:10094428
Deschenes M and Feltz P GABA-induced rise of extracellular potassium in rat dorsal root ganglia: an electrophysiological study in vivo. 1976 Brain Res. pmid:1009435
Deschenes M et al. A model for an estimate in vivo of the ionic basis of presynaptic inhibition: an intracellular analysis of the GABA-induced depolarization in rat dorsal root ganglia. 1976 Brain Res. pmid:1009434
Coyle JT and Yamamura HI Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. 1976 Brain Res. pmid:1009427
Mata MM et al. On GABA function and physiology in the pineal gland. 1976 Brain Res. pmid:1009426
Rosina A et al. GAT-1 developmental expression in the rat cerebellar cortex: basket and pinceau formation. 1999 Neuroreport pmid:10094127
pmid:10091848
Jóźwiak L et al. Behavioral studies of the effects of moderate oligemic hypoxia caused by bilateral clamping of carotid arteries in mice. Impairment of spatial working memory. 1998 Jul-Oct Pol J Pharmacol pmid:10091712
Möck M et al. GABAergic inhibition in the rat pontine nuclei is exclusively extrinsic: evidence from an in situ hybridization study for GAD67 mRNA. 1999 Exp Brain Res pmid:10090666
Rogers HJ and Lietman PS Inhibition by trimethoprim of some effects of epidermal growth factor on human fibroblasts in tissue culture. 1976 Biochem. Pharmacol. pmid:1008900
Ferraro L et al. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. 1999 Neuropsychopharmacology pmid:10088135
Brussaard AB et al. Changes in properties and neurosteroid regulation of GABAergic synapses in the supraoptic nucleus during the mammalian female reproductive cycle. 1999 J. Physiol. (Lond.) pmid:10087349
Alkondon M et al. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. 1999 J. Neurosci. pmid:10087082
Polgár E et al. GABAergic neurons that contain neuropeptide Y selectively target cells with the neurokinin 1 receptor in laminae III and IV of the rat spinal cord. 1999 J. Neurosci. pmid:10087077
Verheugen JA et al. Noninvasive measurements of the membrane potential and GABAergic action in hippocampal interneurons. 1999 J. Neurosci. pmid:10087068
Mozrzymas JW et al. Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors. 1999 J. Neurosci. pmid:10087062
Seidl JJ and Slawson JG Gabapentin for painful diabetic neuropathy. 1999 J Fam Pract pmid:10086757
Subramanian P et al. Temporal oscillations of phosphatases in N-phthaloyl gamma-aminobutyric acid treated rats. 1998 Indian J. Exp. Biol. pmid:10085783
Jensen K et al. Role of presynaptic L-type Ca2+ channels in GABAergic synaptic transmission in cultured hippocampal neurons. 1999 J. Neurophysiol. pmid:10085349
Lin Q et al. Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is modulated by guanosine 3',5'-cyclic monophosphate. 1999 J. Neurophysiol. pmid:10085336
Dvorak-Carbone H and Schuman EM Long-term depression of temporoammonic-CA1 hippocampal synaptic transmission. 1999 J. Neurophysiol. pmid:10085331
Kiyatkin EA and Rebec GV Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats. 1999 Brain Res. pmid:10082887
Maitra R and Reynolds JN Subunit dependent modulation of GABAA receptor function by neuroactive steroids. 1999 Brain Res. pmid:10082863
Messier C et al. Contribution of cholinergic and gabaergic functions to memory processes in BALB/cANnCrlBR mice. 1999 Brain Res. pmid:10082853
Koo B Vigabatrin in the treatment of infantile spasms. 1999 Pediatr. Neurol. pmid:10082337
Mäkelä R et al. Loreclezole and La3+ differentiate cerebellar granule cell GABA(A) receptor subtypes. 1999 Eur. J. Pharmacol. pmid:10082271
Rezayat M et al. Effects of CCK antagonists on GABA mechanism-induced antinociception in the formalin test. 1999 Eur Neuropsychopharmacol pmid:10082222
Biswas B and Carlsson A Effect of intraperitoneally administered GABA on the locomotor activity of mice. 1978 Psychopharmacology (Berl.) pmid:100821
Bloms-Funke P et al. Extracellular single-unit recordings of piriform cortex neurons in rats: influence of different types of anesthesia and characterization of neurons by pharmacological manipulation of serotonin receptors. 1999 J. Neurosci. Res. pmid:10082083
Goshima Y et al. The evidence for tonic GABAergic regulation of basal L-DOPA release via activation of inhibitory GABA(A) receptors in the nucleus tractus solitarii of anesthetized rats. 1999 Neurosci. Lett. pmid:10081972